More medical History on my Dad..For any insight. PET scan in the morning and ill be asking for genetic testing

[ROBYN4ROBBY]

Notes from Care Team

Notes from Care Team

Progress

Subjective

Heme/Onc Problems

ICD-10-CM

1.

Prostate cancer (CMS HCC)

C61

2.

Cancer associated pain

G89.3

Heme/Onc Treatment History

Heme/Onc History

Prostate cancer (CMS HCC)

10/2019 - 10/2020

Chemotherapy

GnRH Agonist Alone

Planned concurrent EBRT but did not occur secondary to COVID pandemic

4/12/2021 -

Cancer Staged

Staging form: Prostate, AJCC 8th Edition

- Clinical stage from 4/12/2021: Stage IIIC (cT1c, cN0, cM0, PSA: 31.9, Grade Group: 5)

-NCCN localized CaP risk group: HIGH RISK

4/2021 -

Chemotherapy

GnRH Agonist

5/2021 - 6/22/2021

Radiation Oncology

EBRT to Prostate and Whole Pelvis with concurrent GnRH Agonist

70 Gy in 28 to pelvis

45 Gy in 28 to whole pelvis

11/2/2022

Biopsy

PSA=8.7, up from 0.9 in July 2022

c/w development of castrate-resistant disease

12/12/2022 - 4/1/2024

Chemotherapy

Apalutamide 240mg PO daily

4/23/2024 - 5/8/2024

Chemotherapy

OP ABIRATERONE (1000 MG PO DAILY) / PREDNISONE (5 MG PO DAILY) (HIGH RISK OR METASTATIC CASTRATION SENSITIVE)

5/16/2024

Surgery

Open radical cystoprostatectomy.Ileal conduit urinary diversion for disease control

Prostatic adenocarcinoma, acinar type (Gleason 5 + 5 = 10; ISUP grade

group 5), involving the urinary bladder and prostate with extensive

necrosis. Invasive carcinoma present at margin

10/21/2024 - 12/18/2024

Chemotherapy

OP DOCETAXEL D1 EVERY 21 DAYS X 6 CYCLES